Alexion Pharmaceuticals (NASDAQ: ALXN) announced today that it will be acquiring commercial-stage biopharmaceutical company Portola Pharmaceuticals (NASDAQ: PTLA) for an…
COVID-19 has been pretty disruptive on clinical-level biotech and pharmaceutical companies worldwide, especially those running on tight budgets. Clinical trials…
ImmunoGen Inc. (IMGN) Q1 2020 earnings call dated May 01, 2020 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications and…